Acne Vulgaris
New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness
Published in Lab Law Weekly, December 5th, 2008
In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), an eight-person jury in Atlantic City has found that pharmaceutical maker Hoffman-La Roche (OTCQX: RHHBY; VTX: ROG.VX) failed to provide adequate warning of the possible condition to three patients who began taking the drug as teenagers and shortly thereafter developed severe forms of IBD. The jury awarded compensatory damages of $12.89 million to be apportioned among the three individuals, now aged in their mid-to-late 20s.
The verdict capped a five-week trial in New Jersey State Superior Court and follows a series of recent plaintiffs' wins...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2008-12-05)
More Articles from Lab Law Weekly
- Able Forensic Investigations, Inc.
Able Forensic Investigations of San Diego Achieves 10 Year Mark - Accertify
Accertify Announces More Customer Wins - Addiction Medicine
Texas Courts Lead U.S. in High-Tech Battle Against DUIs - Akerman Senterfitt
Akerman Senterfitt Expands Healthcare Practice - Akerman Senterfitt
Akerman Senterfitt Expands Labor and Employment Practice - Alcohol Monitoring Systems, Inc.
Failing Economy, Alcohol Combine to Create Dangerous Holiday Season - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
